AID-ICU For Patients

The aim of the trial is to determine whether the drug haloperiodol has a beneficial effect in treating critically ill patients with delirium.

Delirium is the clinical representation of a dysfunctional brain, e.g. caused by critical illness. The trial compares haloperidol with a placebo (saline).

Trial Sponsor

MD, Lone Musaeus Poulsen
Zealand University Hospital, Køge

Overview of Recruitment